|
Status |
Public on Jan 18, 2019 |
Title |
MDA-MB-436 shEZH2 |
Sample type |
SRA |
|
|
Source name |
human MDA-MB-436 cell line
|
Organism |
Homo sapiens |
Characteristics |
treatment: shEZH2 treatment
|
Treatment protocol |
Cells were transduced with GSK343 inhibitor, shEZH2 or no treatment as control.
|
Growth protocol |
Cells were cultured in DMEM medium with 10% FBS and penicillin/streptomycin in 37°C incubator.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted using Qiagen RNeasy Plus Mini Kit. Libraries were prepared by BGI (Hongkong).
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
BGISEQ-500 |
|
|
Data processing |
All RNAseq fastq files were aligned to human genome (GRCh38) using STAR with parameter --outFilterMismatchNmax 2.
Gene read numbers were counted using HTSeq-count.
Reads Per Kilobase of exon per Megabase of library size (RPKM) were calculated using a protocol from Chepelev et al., Nucleic Acids Research, 2009. In short, exons from all isoforms of a gene were merged to create one meta-transcript. The number of reads falling in the exons of this meta-transcript were counted and normalized by the size of the meta-transcript and by the size of the library.
Genome_build: GRCh38
Supplementary_files_format_and_content: tab-delimited text files include RPKM values for all samples
|
|
|
Submission date |
Mar 27, 2018 |
Last update date |
Jan 22, 2019 |
Contact name |
Jieyi Xiong |
Organization name |
VIB-KULeuven Center for Cancer Biology
|
Street address |
Herestraat 49, box 912
|
City |
Leuven |
ZIP/Postal code |
3000 |
Country |
Belgium |
|
|
Platform ID |
GPL23227 |
Series (1) |
GSE112378 |
Targeting EZH2 increases the vulnerability of triple-negative breast cancer |
|
Relations |
BioSample |
SAMN08800368 |
SRA |
SRX3852244 |